) The Data Management Core at the Moffitt Cancer Center has three main functions: A. Assistance in patient enrollment and treatment on clinical trials B. Clinical trials data management C. Quality assurance of data Clinical trials data management is centrally directed, yet based in the interdisciplinary clinical programs where the DMC staff function as members of the multidisciplinary teams. In addition to the functions noted above, the DMC is responsible for recruitment and training of clinical research staff. Staff assignments are based upon accrual, utilizing a staffing ratio of approximately 40 patient accruals (therapeutic) to 1.0 FTE. Annual patient accrual of the Cancer Center for fiscal year '99 exceeds 3700, with over 975 patients on therapeutic studies. In addition to CCSG support, the data management core is supported with institutional funds and charge-back revenue from industrial studies and cooperative groups. The Cancer Center has committed substantial support to Data Management functions and the Clinical Trials Finance Office has been successful in recovering significant support from pharmaceutical studies for this purpose. However, institutionally based, peer reviewed studies will continue to grow, especially with the Phase I/II Clinical Research Unit expansion. The increase in patient accrual, especially to innovative phase I/II clinical trials, and the additional burdens of an increasing population to follow requires additional staff. We are requesting a total of 1.35 FTE.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA076292-05
Application #
6602141
Study Section
Project Start
2002-02-01
Project End
2003-01-31
Budget Start
Budget End
Support Year
5
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of South Florida
Department
Type
DUNS #
City
Tampa
State
FL
Country
United States
Zip Code
33612
Dai, Juncheng; Li, Zhihua; Amos, Christopher I et al. (2018) Systematic analyses of regulatory variants in DNase I hypersensitive sites identified two novel lung cancer susceptibility loci. Carcinogenesis :
Cherezov, Dmitry; Hawkins, Samuel H; Goldgof, Dmitry B et al. (2018) Delta radiomic features improve prediction for lung cancer incidence: A nested case-control analysis of the National Lung Screening Trial. Cancer Med 7:6340-6356
Simmons, Vani N; Sutton, Steven K; Meltzer, Lauren R et al. (2018) Long-term outcomes from a self-help smoking cessation randomized controlled trial. Psychol Addict Behav 32:710-714
Wheldon, Christopher W; Schabath, Matthew B; Hudson, Janella et al. (2018) Culturally Competent Care for Sexual and Gender Minority Patients at National Cancer Institute-Designated Comprehensive Cancer Centers. LGBT Health 5:203-211
Lin, Hui-Yi; Huang, Po-Yu; Chen, Dung-Tsa et al. (2018) AA9int: SNP interaction pattern search using non-hierarchical additive model set. Bioinformatics 34:4141-4150
Neumeyer, Sonja; Banbury, Barbara L; Arndt, Volker et al. (2018) Mendelian randomisation study of age at menarche and age at menopause and the risk of colorectal cancer. Br J Cancer 118:1639-1647
Hellmann, Matthew D; Callahan, Margaret K; Awad, Mark M et al. (2018) Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer. Cancer Cell 33:853-861.e4
Trabert, Britton; Poole, Elizabeth M; White, Emily et al. (2018) Analgesic Use and Ovarian Cancer Risk: An Analysis in the Ovarian Cancer Cohort Consortium. J Natl Cancer Inst :
Palmer, Amanda M; Brandon, Thomas H (2018) How do electronic cigarettes affect cravings to smoke or vape? Parsing the influences of nicotine and expectancies using the balanced-placebo design. J Consult Clin Psychol 86:486-491
Dougoud-Chauvin, Vérène; Lee, Jae Jin; Santos, Edgardo et al. (2018) Using Big Data in oncology to prospectively impact clinical patient care: A proof of concept study. J Geriatr Oncol 9:665-672

Showing the most recent 10 out of 1254 publications